SDGR Schrödinger, Inc.
SDGR Schrödinger, Inc.
Healthcare · Health Information Services
Desk view
Market read
POC $12.38 · VWAP $18.20 · +24.2% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
1 related campaign
SDGR Price Structure
Loading timeframes…
Peers
Every watchlist SDGR belongs to, members best 30-day change first — SDGR highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@biotech-capital-cycle
@ibb
Reported the quarter ending 2026-06-30: revenue $59M, diluted EPS $0.08, net income $6M (SEC filing, revenue corroborated by the desk's provider cache). Across the print the stock moved +13.8% (close before → first close after).
full note →Against street estimates
How SDGR's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
Recent news
Headlines about SDGR from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled today · Oct 17
- Schrodinger (SDGR) Q2 2026 Earnings Results & Call Transcript
- Schrödinger Reports Second Quarter 2026 Financial Results | Nasdaq
- Schrödinger (SDGR) Q1 2026 Earnings Transcript - The Globe and Mail
- Schrödinger Reports First Quarter 2026 Financial Results
- Schrödinger Reports Fourth Quarter and Full-Year 2025 Financial Results
SDGR research tape
42 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.